Your browser doesn't support javascript.
loading
Retrospective Analysis of Irregular Antibodies Causing Hemolytic Disease of the Fetus and Newborn in Jiangxi Province / 中国实验血液学杂志
Article de Zh | WPRIM | ID: wpr-971127
Bibliothèque responsable: WPRO
ABSTRACT
OBJECTIVE@#To analyze the characteristics of antibody-specific distribution, laboratory detection results of hemolytic disease of the fetus and neonatal(HDFN) caused by irregular blood group antibodies other than ABO, and its correlation with the clinical situation.@*METHODS@#The non-ABO-HDFN cases in our hospital from October 2012 to December 2021 were selected as the research objects, and the cases diagnosed with ABO-HDFN in the same period were randomly selected as the control group, and the data of antibody specific distribution, total bilirubin, direct antibodies, maternal history, age of the children, the presence or absence of combined ABO-HDFN, and whether to exchange/transfuse blood were retrospectively analyzed. The characteristics of non-ABO-HDFN in Jiangxi province were analyzed.@*RESULTS@#The detection rate of non-ABO-HDFN in Jiangxi province increased. Among 187 non ABO-HDFN cases, the highest percentage of Rh-HDFN was detected (94.6%). Compared with the control group of ABO-HDFN, the non-ABO-HDFN had higher mean integral value of direct antibody, higher peak total bilirubin, and longer duration. Anti-M-HDFN may have severe disease but the direct antibody weak positive/negative, it was easy missed in clinical and delayed the treatment. There is no correlation between the specificity of irregular antibodies, the sex of the child, the mother's previous childbirth history, the presence or absence of combined ABO-HDFN and the need for blood exchange/transfusion(P>0.05).@*CONCLUSION@#The irregular antibodies of causing non ABO-HDFN in Jiangxi area are mainly Rh blood group system, followed by MNS blood group system. Understanding the characteristics of HDFN disease, serological features and the correlation with clinical indexes will help to detect and treat non ABO-HDFN in time and reduce the risk of complications.
Sujet(s)
Mots clés
Texte intégral: 1 Indice: WPRIM Sujet Principal: Antigènes de groupe sanguin / Système ABO de groupes sanguins / Études rétrospectives / Érythroblastose du nouveau-né / Foetus / Hémopathies / Hémolyse / Alloanticorps Limites du sujet: Child / Female / Humans / Newborn langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2023 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Antigènes de groupe sanguin / Système ABO de groupes sanguins / Études rétrospectives / Érythroblastose du nouveau-né / Foetus / Hémopathies / Hémolyse / Alloanticorps Limites du sujet: Child / Female / Humans / Newborn langue: Zh Texte intégral: Journal of Experimental Hematology Année: 2023 Type: Article